°øÁö»çÇ×

HOME > ÇÐȸ¼Ò°³   >   °øÁö»çÇ×

´Ù¹ß¼º°ñ¼öÁ¾¿¬±¸È¸ Á¦ 5ȸ ASH Myeloma Review °³ÃÖ ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
ÀÛ¼ºÀÏ
2009-03-09
Á¶È¸
6119


´ëÇÑÇ÷¾×ÇÐȸ ´Ù¹ß¼º °ñ¼öÁ¾ ¿¬±¸È¸´Â ¿À´Â 3¿ù 21ÀÏ (Åä) ½Å¶óÈ£ÅÚ ¿µºó°ü¿¡¼­ Á¦ 5ȸ ASH  Myeloma 
Review¸¦ °³ÃÖÇÕ´Ï´Ù.


ÀÌ ÀÚ¸®¿¡¼­´Â ÀÌŸ®ÀÇ Àú¸íÇÑ ÇÐÀÚÀÎ Dr. BoccadoroÀÇ ´Ù¹ß¼º°ñ¼öÁ¾ÃֽŠÁö°ß¿¡ ´ëÇÑ Æ¯°­°ú ¿µ±¹ÀÇ Dr.HobbsÀÇ free light chainÀÇ ÃֽŠÁö°ß¿¡ ´ëÇÑ Æ¯°­µµ ÁغñµÇ¾î ÀÖ½À´Ï´Ù.



³¯Â¥ : 2009³â 3¿ù 21ÀÏ (Åä)

½Ã°£ : ¿ÀÀü 10½Ã~ ¿ÀÈÄ 3:30ºÐ

Àå¼Ò : ½Å¶óÈ£ÅÚ ¿µºó°ü 


Agenda

Session 1          Chairman: ¹Ú¼±¾ç ±³¼ö(¼­¿ïÀÇ´ë), ÀÌÀçÈÆ ±³¼ö(°¡ÃµÀÇ´ë)

10:00 ~ 10:25     Pathophysiology and pre-clinical studies--¹ÚÇö°æ ±³¼ö(¼­¿ïÀÇ´ë)

10:25 ~ 10:30     Discussion

10:30 ~ 10:55     Frontline treatment for non-transplantation candidates--¹®¿µÃ¶ ±³¼ö(ÀÌÈ­ÀÇ´ë)

10:55~11:00    Discussion

11:00 ~ 11:25     Frontline treatment for Transplantation candidates 1--ÀÌÇö±Ô ±³¼ö(ÀÎÇÏÀÇ´ë)

11:25 ~ 11:50     Frontline treatment for Transplantation candidates 2--¹®ÁØÈ£ ±³¼ö(°æºÏÀÇ´ë)

11:50 ~ 12:00     Discussion

12:00 ~ 12:30     Lunch Break

Session 2                  Chairman: ±èȿö ±³¼ö(¾ÆÁÖÀÇ´ë), À̵¿¼ø ±³¼ö(¼­¿ïÀÇ´ë)

12:30 ~ 13:00     Dr.Boccadoro (Italy) : Recent advances in the treatment of Multiple Myeloma 

13:00 ~ 13:10     Discussion

13:10 ~ 13:40     Dr. Hobbs (UK): Applications of serum free light chain assays

13:40 ~ 13:50     Discussion

13:50 ~ 14:00     Break

Session 3.                 Chairman:Á¶°æ»ï ±³¼ö(°æÈñÀÇ´ë), À±¼º¼ö ±³¼ö(¼­¿ïÀÇ´ë)

14:00 ~ 14:25     Treatment for Relapsed/ Refractory disease--±èº´¼ö ±³¼ö(¼­¿ïÀÇ´ë)

14:25 ~ 14:30     Discussion

14:30 ~ 14:55     Treatment for High Risk Patients, Cytogenetic Risk Factors, Renal impairment--¿À¼®Áß ±³¼ö(¼º±Õ°üÀÇ´ë)

14:55 ~ 15:00     Discussion

15:00 ~ 15:25     The role of Cyclophosphamide in the treatment of MM--ÀÌÀ±¾Æ ±³¼ö(Ä«Å縯ÀÇ´ë)

15:25 ~ 15:30     Discussion